Enzymes that are able to oxidatively cleave carotenoids at specific positions have been identified in animals and plants. The first such enzyme to be identified was a nine-cis-epoxy carotenoid dioxygenase from maize, which catalyzes the rate-limiting step of abscisic acid biosynthesis. Similar enzymes are necessary for the synthesis of vitamin A in animals and other carotenoidderived molecules in plants. In the model plant, Arabidopsis, there are nine hypothetical proteins that share some degree of sequence similarity to the nine-cis-epoxy carotenoid dioxygenases. Five of these proteins appear to be involved in abscisic acid biosynthesis. The remaining four proteins are expected to catalyze other carotenoid cleavage reactions and have been named carotenoid cleavage dioxygenases (CCDs). The hypothetical proteins, AtCCD7 and AtCCD8, are the most disparate members of this protein family in Arabidopsis. The max3 and max4 mutants in Arabidopsis result from lesions in AtCCD7 and AtCCD8. Both mutants display a dramatic increase in lateral branching and are believed to be impaired in the synthesis of an unidentified compound that inhibits axillary meristem development. To determine the biochemical function of AtCCD7, the protein was expressed in carotenoid-accumulating strains of Escherichia coli. The activity of AtCCD7 was also tested in vitro with several of the most common plant carotenoids. It was shown that the recombinant AtCCD7 protein catalyzes a specific 9 -10 cleavage of ␤-carotene to produce the 10-apo-␤-carotenal (C 27 ) and ␤-ionone (C 13 ). When AtCCD7 and AtCCD8 were co-expressed in a ␤-carotene-producing strain of E. coli, the 13-apo-␤-carotenone (C 18 ) was produced. The C 18 product appears to result from a secondary cleavage of the AtCCD7-derived C 27 product. The sequential cleavages of ␤-carotene by AtCCD7 and AtCCD8 are likely the initial steps in the synthesis of a carotenoid-derived signaling molecule that is necessary for the regulation lateral branching.
Apocarotenoids are a diverse class of compounds that are derived from the oxidative cleavage of carotenoids. These compounds serve important biological functions in a variety of organisms. Vitamin A, for example, is required for vision and development in animals. In plants, abscisic acid is necessary for seed development and adaptation to various environmental stresses. The synthesis of these apocarotenoids and others is catalyzed by a class of oxygenases that cleave specific double bonds resulting in two products with carbonyls at the site of cleavage. For many years it was believed that the enzymes that catalyze these reactions were dioxygenases. In a recent study, it was found that oxygen in one of the products comes from water (1) , indicating that these enzymes may be monooxygenases. For simplicity, all enzymes will be referred to the name given when originally described.
In plants, nine-cis-epoxy-carotenoid dioxygenases (NCEDs) 1 catalyze the rate-limiting step in abscisic acid biosynthesis. An NCED from maize was the first carotenoid cleavage enzyme to be cloned and characterized (2, 3) . A number of NCEDs (4 -7) and similar enzymes that are necessary for the synthesis of other apocarotenoids have since been identified in a variety of plants (8 -10) . The enzymes that cleave ␤-carotene to form two molecules of retinal in animals also belong to this family (11) (12) (13) (14) .
Within the genome sequence of the model plant, Arabidopsis, there are nine hypothetical proteins that share some degree of sequence similarity to the NCEDs. Five of these proteins are believed to be involved in abscisic acid synthesis (15) . Four members of this protein family in Arabidopsis do not cluster with previously characterized NCEDs and are considered unlikely to be abscisic acid biosynthetic enzymes. These proteins may, however, catalyze other carotenoid cleavage reactions and are more appropriately referred to as carotenoid cleavage dioxygenases (CCDs). The AtCCD1 protein, for example, catalyzes the symmetric 9 -10, 9Ј-10Ј cleavage of various carotenoids (8) . The specific biochemical functions for the remaining three CCDs from Arabidopsis (AtCCD4, -7, and -8) have not yet been reported.
The max4 mutant in Arabidopsis and the rms1 mutant in pea result from a lesion in AtCCD8 and a pea ortholog (16) . Both mutants display an increase in lateral branching and are believed to be impaired in the synthesis of an unknown compound that inhibits axillary meristem development or bud outgrowth. The max3 mutant also displays an increase in lateral branching that results from a lesion in the AtCCD7 gene (17) , indicating that AtCCD7 is also involved in the synthesis of this inhibitor. The biochemical characterization of AtCCD7 and AtCCD8 is an important step in identifying the biologically active compound. It has been reported that the expression of AtCCD7 in carotenoid-producing strains of Escherichia coli results in a reduced accumulation of carotenoids and the production of some apocarotenoids (17) . However, the specific reaction catalyzed by AtCCD7 has not yet been established. It is demonstrated here that the recombinant AtCCD7 protein catalyzes a 9 -10 cleavage of ␤-carotene to produce the 10Ј-apo-␤-carotenal (C 27 ) and ␤-ionone (C 13 ). The AtCCD8 protein is able to catalyze a secondary cleavage of the 10Ј-apo-␤-carotenal at the 13-14 position to produce the 13-apo-␤-carotenone (C 18 ).
EXPERIMENTAL PROCEDURES
Cloning of AtCCD7 and AtCCD8 -A cDNA clone of AtCCD7 was obtained by reverse transcription-PCR with RNA isolated from 1-weekold Arabidopsis seedlings. Total RNA was reverse transcribed with Superscript from Invitrogen and an 18-mer oligo (dT) primer. The AtCCD7 gene was then amplified with platinum Taq polymerase from Invitrogen and the primers listed in Table I . The sequence of the cloned cDNA was identical with the sequence in GenBank TM (NM_130064). The AtCCD8 ORF in the pUNI51 vector was produced by the Salk/ Stanford/PGEC consortium (18) and obtained from the Arabidopsis stock center (stock number U19580). Subsequent subcloning of AtCCD7 and AtCCD8 for recombinant protein expression is described in Table I .
Expression and Analysis of AtCCD7 in Carotenoid-accumulating Strains of E. coli-Most proteins in this study were expressed with an N-terminal glutathione S-transferase tag (Table I ). For expression in carotenoid-accumulating strains of E. coli (19) , 2-ml cultures were grown overnight in LB medium with 100 g ml Ϫ1 ampicillin and 35 g ml Ϫ1 chloramphenicol. The overnight cultures were used to inoculate a 30-ml culture of LB with the same antibiotics. After 24 h at 28°C, 0.1 mM isopropyl ␤-D-thiogalactopyranoside was added, and the cultures were left at room temperature for an additional 48 h. At the same time the recombinant protein was expressed, ferrous sulfate was added to a final concentration of 10 mg liter Ϫ1 . For quantitative analysis of carotenoid accumulation, 1 ml of culture was centrifuged, and the medium was discarded. The cell pellet was resuspended in 100 l of formaldehyde, and then 1 ml of the ethanol was added. The tubes were placed at 4°C for 3 h before the cell debris was removed by centrifugation. For ␤-carotene-and zeaxanthin-accumulating strains of E. coli, absorbance was measured with a spectrophotometer at 453 nm. For the lycopene-accumulating strains, absorbance was measured at 472 nm. The carotenoid content was calculated with known extinction coefficients.
For analysis of apocarotenoid products, a culture was centrifuged, and the cell pellet was extracted sequentially with formaldehyde, methanol, and diethyl ether. The media were partitioned into an equal volume of diethyl ether. Both the cell extract and the medium partition were washed with water, and the diethyl ether layer was retained. The volume of the diethyl ether was reduced under nitrogen, and a solution of 10% KOH in methanol was added to saponify the samples. After 30 min, the samples were partitioned into diethyl ether and washed with water. The diethyl ether layer was dried under a gentle stream of nitrogen, and the samples were stored at Ϫ80°C until HPLC analysis.
The E. coli extracts were analyzed on a Waters 600 HPLC (Milford, MA) equipped with a Waters 996 photodiode array detector. Samples were injected on a 5-m C 18 Adsorbosil column from Alltech (Deerfield, IL) and eluted with 50% acetonitrile and water at 1 ml min Ϫ1 for 4 min followed by a linear gradient to 100% acetonitrile over 16 min. The gradient was then shifted to 100% acetone over 12 min and left at 100% acetone for an additional 5 min.
In Vitro Assays with Recombinant AtCCD7-For protein expression, 5 ml of an overnight culture was used to inoculate a 100-ml culture in 2ϫ YT medium (per liter: 16 g of tryptone, 10 g of yeast extract, and 5 g of NaCl). Cultures were grown at 37°C until an A 600 of 0.7 was reached. Expression of proteins was induced by the addition of 0.2 mM isopropyl ␤-D-thiogalactopyranoside, and the cultures were grown at 28°C for an additional 5 h. The E. coli cells were harvested by centrifugation and resuspended in 4 ml of lysis buffer (40 mM Tris, pH 7.5, 20 mM NaCl, 2 mM MgCl 2 , 100 g lysozyme, and 100 units of endonuclease). The cells were left on ice for 20 min and then frozen in liquid nitrogen. After cells were thawed, Triton X-100 was added to a final concentration of 0.25%, and the cells were shaken on ice for 30 min. The recombinant protein was bound to glutathione-agarose from Sigma, washed three times with Tris-buffered saline, and then released by cleavage with Factor Xa from Novagen (Madison, WI) for 7 h at 4°C. The carotenoid substrates were extracted from plant tissues and purified by HPLC as described previously (20) . Assays contained 0.1% Triton X-100, 0.5 mM FeSO 4 , 5 mM ascorbate, and the appropriate carotenoid substrate in 100 mM Tris, pH 7.0. The assay products were partitioned into ethyl acetate, dried under N 2 , and analyzed by HPLC or thin-layer chromatography. To determine the K m and V max values, the Michaelis-Menten equation was solved by non-linear regression using Sigma Plot 4.01 from Jandel Scientific (San Rafael, CA).
The Co-expression of AtCCD7 and AtCCD8 in Carotenoid-accumulating Strains of E. coli-For expression of AtCCD8 or co-expression of AtCCD7 and AtCCD8, the BL21 (AI) strain from Invitrogen was used, and cultures were grown as described above. For induction of the tac promoter expressing AtCCD7, isopropyl ␤-D-thiogalactopyranoside was added to a final concentration of 0.1 mM. Induction of the AtCCD8 protein, under the control of a T7 promoter, was achieved by the addition of 0.02% arabinose. The cells and media were extracted and analyzed as described above.
Characterization of Apocarotenoid Products-The apocarotenoid products were purified by reverse phase HPLC (described above), re- With Cre-lox site-specific recombination, the AtCCD8 ORF was placed into pHB3-His 6 for expression as a histidine-tagged protein under the control of a T7 promoter amp
With T7 promoter and terminator primers, the promoter and the AtCCD8 ORF from pAT1 was amplified and subcloned into the ZraI site of pGEX 5x-3 amp
With T7 promoter and terminator primers, the promoter and the AtCCD8 ORF from pAT1 was amplified and subcloned into the ZraI site of pBHS5 amp r duced with NaBH 4 , and further purified by normal phase HPLC on an analytical porasil column from Waters Corporation (Milford, MA) that was equilibrated with 97:3 (hexane:ethyl acetate) at 2 ml min Ϫ1 . The column was eluted with a linear gradient to 50% ethyl acetate over 12 min. Fractions were collected, dried, and dissolved in hexane to determine their absorption spectra. The C 27 product of AtCCD7, 10Ј-apo-␤-carotenal, and the NaBH 4 reduced form were also analyzed by positive ion fast atom bombardment. Samples were introduced by direct insertion probe with 3-nitrobenzyl alcohol as the matrix. The molecular ions (M ⅐ and M ⅐ ؉1 ) for the 10Ј-apo-␤-carotenal and carotenol were apparent. A high-resolution spectrum for the M ⅐ of the 10Ј-apo-␤-carotenol was also obtained. The trimethylsilyl derivative of the 13-apo-␤-carotenol was analyzed by gas chromatography-mass spectrometry with a DB5-MS column (30 m with an inner diameter of 0.32 mm, 0.25-m film, J&W Scientific) and the following temperature program: 100°C for 1 min, 100 -230°C at 40°C/min, 230 -280°C at 8°C/min, and 280 -300°C at 20°C/min.
RESULTS
Expression of ATCCD7 in Carotenoid-accumulating Strains of E. coli-To determine the reactions catalyzed by AtCCD7, a glutathione S-transferase fusion protein was expressed in several carotenoid-accumulating strains of E. coli. In previous studies, the expression of a functional carotenoid cleavage enzyme in these strains resulted in a reduced or altered color development (8 -10, 13, 21) . A moderate level of AtCCD7 expression in a lycopene-producing strain (pACLYC) or zeaxanthin-producing strain (pACZEAX) had little effect on color development (Fig. 1, A and B) . Conversely, expression of AtCCD7 in a ␤-carotene-producing strain (pACBETA) had a significant effect on the accumulation of this carotenoid (Fig. 1, A and B) .
The cells and media from the AtCCD7 expression strains were extracted and analyzed by reverse phase HPLC. Two major compounds were detected in the pACBETA/AtCCD7 strain that were not detected in the pACBETA strain with an empty vector. One product had a UV-visible spectrum and retention time that was identical to ␤-ionone (C 13 ) (Fig. 2A) . The second product had a UV-visible spectrum that was consistent with the 10Ј-apo-␤-carotenol (C 27 ) (Fig. 2B) (22, 23) . Several smaller peaks, which had similar retention times and absorption spectra, are most likely cis isomers of the C 27 product. These apocarotenoids would result from the 9 -10 cleavage of ␤-carotene (Fig. 3) . The initial cleavage product would be an aldehyde, but it is subsequently reduced to the corresponding alcohol by E. coli. The reduction of the aldehyde cleavage products to alcohols by E. coli has been reported previously (8, 13) . When AtCCD7 was expressed in a lycopene-producing strain of E. coli, a small amount of a compound with a UV-visible spectrum similar to the10Ј-apolycopenol was detected (Fig. 2C) . No apocarotenoid products were detected when AtCCD7 was expressed in a zeaxanthinaccumulating strain.
In Vitro Assays with Recombinant AtCCD7-To further explore the specificity of AtCCD7 and delimit the endogenous substrates, in vitro assays were performed with the affinitypurified protein and several common plant carotenoids. These assays were analyzed by thin-layer chromatography (Fig. 4) and HPLC (supplemental Fig. 2) . No products were detected with lycopene, lutein, zeaxanthin, violaxanthin, or neoxanthin as substrates. A single product was apparent in assays with ␤-carotene. The UV-visible spectra of the enzyme product and of the NaBH 4 reduced form were very similar to published spectra for the 10Ј-apo-␤-carotenal and the 10Ј-apo-␤-carotenol, respectively (supplemental Fig. 2B) (23) . The [M] ⅐ and [M ϩ H] ⅐ ions for the 10Ј-apo-␤-carotenal and 10Ј-apo-␤-carotenol were detected by fast atom bombardment-mass spectroscopy, and a high-resolution spectrum of the reduced product matched the molecular formula for the 10Ј-apo-␤-carotenol, C 27 H 38 O. The calculated mass of the apocarotenol is 378.29230, whereas the experimentally determined mass of the compound was 378.2928 (an error of 1.3 ppm from the calculated).
The AtCCD7 protein contains a probable chloroplast targeting sequence of 31 amino acids (TargetP V1.01), which is consistent with a role in carotenoid metabolism. A truncated AtCCD7 protein (587 amino acids) lacking the N-terminal targeting sequence was also able to catalyze the 9 -10 cleavage of ␤-carotene (data not shown). The addition of watermiscible organic solvents has been shown to enhance the activity of lignostilbene dioxygenases (24) , which share sequence similarity to the CCDs and catalyze a similar double bond cleavage reaction. The addition of methanol to in vitro assays with AtCCD7 had a stimulatory effect on activity at concentrations up to 25% (data not shown). 
Co-expression of AtCCD7 and AtCCD8 in Carotenoid-accumulating Strains-No apocarotenoids were detected with the expression of AtCCD8 in the carotenoid-accumulating strains of E. coli (data not shown). Because mutations in AtCCD7 and
AtCCD8 result in the same phenotype, it is likely that the two gene products function in the same pathway. So, a construct for the co-expression of AtCCD7 and AtCCD8 was transformed into the carotenoid-accumulating strains. In addition to the AtCCD7 cleavage products, ␤-ionone and the 10Ј-apo-␤-carotenol, a third product was identified in the ␤-carotene co-expression strain (Fig. 5A and supplemental Fig. 1D ). The absorption spectrum of the product in hexane before and after reduction with NaBH 4 (Fig. 5B) is similar to the 13-apo-␤-carotenone and carotenol (C 18 ) (25) . A trimethylsilyl derivative of the reduced product was analyzed by gas chromatography-mass spectrometry (Fig. 6) . The observed molecular ion of 332 is the expected mass for the trimethylsilyl derivative of the 13-apo-␤-carotenol. An authentic standard of 13-apo-␤-carotenone was produced according to a synthesis described previously (26) . The chromatography, UV-visible spectra, and mass spectra of the E. coli product and the synthetic product were the same.
The absence of the 13-apo-␤-carotenone when AtCCD8 is 
FIG. 4.
Thin-layer chromatography analysis of assays with the recombinant AtCCD7 protein and some common plant carotenoids. Enzyme assay products were separated on a thin-layer silica plate that was developed in hexane and 2-propanol (90:10). Following chromatography, the plate was sprayed with 2,4-dinitrophenylhydrazine to detect aldehydes and ketones. The 10Ј-apo-␤-carotenal is indicated by an arrow. HPLC analysis of in vitro assays with lycopene and ␤-carotene are presented in supplemental Fig. 2.   FIG. 5 . A-C, HPLC analysis of pACBETA strains with a construct for the expression of AtCCD8 (A), the co-expression of AtCCD7 and AtCCD8 (B), or the co-expression of ␤-Diox II and AtCCD8 (C). Contour plots for the expression of AtCCD8 and the co-expression of AtCCD7 and AtCCD8 are presented in supplemental Fig. 1, C and D . D, the UV-visible spectra of 13-apo-␤-carotenone (C 18 ) and the reduced product, 13-apo-␤-carotenol, in hexane.
expressed alone in the ␤-carotene strain indicates that ATCCD8 cleaves the C 27 product, the 10Ј-apo-␤-carotenal or carotenol (Fig. 7) . A C 9 product may also result from this cleavage reaction, but it has not yet been identified. To determine whether the synthesis of the 13-apo-␤-carotenone required a specific interaction between the AtCCD7 and AtCCD8 proteins, a construct was made for the co-expression of ␤-Diox II from mouse and AtCCD8. The ␤-Diox II also catalyzes a 9 -10 cleavage of ␤-carotene (22) , but it shares only 13% identity and 23% similarity with AtCCD7. Co-expression of ␤-Diox II and AtCCD8 also resulted in the production of 13-apo-␤-carotenone (Fig. 5C ).
DISCUSSION
The more axillary branching mutants, max3 and max4, result from lesions in the AtCCD7 and AtCCD8 genes, respectively (16, 17) . Because of an inability to repress the outgrowth of axillary buds, the max mutants display an increase in lateral branching and have a bushy appearance. In many plants, the outgrowth of axillary buds is inhibited by the shoot apex. This phenomenon is often referred to as apical dominance and is regulated in large part by the plant hormone, auxin. Auxin is synthesized in the shoot apex and transported to the base of the plant where it inhibits lateral bud outgrowth. If the shoot apex is damaged, auxin levels are reduced and lateral buds may be released from dormancy. There are, however, several lines of evidence to indicate that auxin does not inhibit the outgrowth of axillary buds directly. Grafting experiments with branching mutants in various species have provided strong evidence for the existence of another long-distance signal that inhibits the outgrowth of axillary buds. The phenotype of several branching mutants in pea (rms1, -2, and -5), the max1, 3, and 4 mutants in Arabidopsis, and the decreased apical dominance mutant in petunia (dad1-1) can be rescued by grafting to a wild type rootstock (16, (27) (28) (29) . These results indicate that a compound that is synthesized in the root is capable of inhibiting axillary bud outgrowth. Because the compound moves acropetally from the root to the shoot, it is most likely transported through the xylem. Considering that the AtCCD7 and AtCCD8 proteins are similar to carotenoid cleavage dioxygenases characterized previously, it is likely that the inhibitor of axillary bud outgrowth is a carotenoid-derived molecule (2, 8, 9, 10 ).
In plants, the cyclization of lycopene is a major branch point in carotenoid biosynthesis. The introduction of two ␤-rings produces ␤-carotene, which may subsequently be converted to zeaxanthin, violaxanthin, and neoxanthin. The introduction of a ␤-ring and an ⑀-ring produces ␣-carotene, which is converted primarily to lutein in most tissues. The lut2 mutant in Arabidopsis is unable to produce ␣-carotene and lutein (30) and has no branching phenotype. Therefore, it is unlikely that either of these carotenoids is a precursor of the lateral branch inhibitor. By the same rationale, mutants impaired in epoxy-carotenoid synthesis (20) indicate that violaxanthin and neoxanthin are not the precursors of the lateral branching inhibitor. The most likely precursor of the branching inhibitor would then be zeaxanthin, ␤-carotene, or an acyclic precursor.
The recombinant AtCCD7 protein was able to catalyze the 9 -10 cleavage of ␤-carotene to produce the 10Ј-apo-␤-carotenol (C 27 ) and ␤-ionone (C 13 ). The AtCCD1 protein and homologs from other plants also catalyze a 9 -10 cleavage reaction (8, 10) . There are, however, several key distinctions between the reactions catalyzed by AtCCD1 and AtCCD7. The recombinant AtCCD1 protein cleaves various carotenoids symmetrically at both the 9 -10 and 9Ј-10Ј positions. Therefore, AtCCD1 does not produce the 10Ј-apo-␤-carotenal.
Because AtCCD7 and AtCCD8 have both been implicated in the synthesis of a lateral branching inhibitor, the two proteins were co-expressed in the carotenoid-accumulating strains of E. coli. When co-expressed in the ␤-carotene-accumulating strain, the C 27 and C 13 products of AtCCD7 were detected. A third product was also produced by this strain and identified as the 13-apo-␤-carotenone (C 18 ). Because this product was not detected when AtCCD8 was expressed by itself, it most likely results from a secondary cleavage of the C 27 product of AtCCD7. A C 9 product may also result from this cleavage reaction, but it has not yet been identified. The lignostilbene dioxygenases, which share sequence similarity with the CCDs and catalyze a similar cleavage reaction, have been shown to function as homodimers or heterodimers (32) . Direct analysis of AtCCD7 and AtCCD8 dimer formation was complicated because the majority of the recombinant AtCCD8 protein was insoluble (data not shown). The C 18 compound was also produced when AtCCD8 was co-expressing with a 9 -10 cleavage enzyme from mouse (␤-Diox II), providing indirect evidence that dimerization is not essential for the activity of AtCCD8. Formation of an AtCCD7-AtCCD8 heterodimer could, however, increase the rate of the second cleavage reaction.
The phenotype of the max3/atccd7 and max4/atccd8 mutants and the biochemical evidence presented here suggest that AtCCD7 and AtCCD8 are necessary for the synthesis of an apocarotenoid that inhibits axillary bud outgrowth. The cleavage of ␤-carotene by AtCCD7 to a C 27 product is likely the first committed step in the biosynthetic pathway of this inhibitor. The C 27 product may subsequently be cleaved by AtCCD8 to form the 13-apo-␤-carotenone (C 18 ) and a C 9 product. Either of the AtCCD8 cleavage products could give rise to the biologically active inhibitor. Grafting experiments with the max1 mutant in Arabidopsis indicate that this mutant is also impaired in the synthesis of the branching inhibitor (29) . Therefore, it is likely that there is one additional step in the pathway. The identification of the biologically active compound will require the characterization of the MAX1 gene product and the development of a bioassay to confirm the role of the inhibitor in regulating lateral branching.
